Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FSPG PET/CT in Lung Cancer and Pulmonary Nodules
NCT02448225Phase 2Completed
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Start
- Jun 2015
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Florilglutamic acid F-18 in lung cancer, Solitary pulmonary nodule (SPN), sponsored by Vanderbilt-Ingram Cancer Center. Started Jun 2015; status: completed.
02
Drugs
Florilglutamic acid F-18
03
Conditions
lung cancerSolitary pulmonary nodule (SPN)
Beyond the preview
Go deeper on NCT02448225.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448225.